At the time of writing, Phio Pharmaceuticals Corp [PHIO] stock is trading at $1.02, up 9.91%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PHIO shares have gain 14.58% over the last week, with a monthly amount glided 67.82%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 6, March 2024, Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disorders. In a post published today on Yahoo Finance, Phio’s Compound RXI-185 and RXI-231 designed to treat photo-aging and hyperpigmentation.
From an analyst’s perspective:
Phio Pharmaceuticals Corp [NASDAQ: PHIO] stock has seen the most recent analyst activity on August 05, 2020, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $4.
For the past year, the stock price of Phio Pharmaceuticals Corp fluctuated between $0.50 and $12.27. Phio Pharmaceuticals Corp [NASDAQ: PHIO] shares were valued at $1.02 at the most recent close of the market.
Analyzing the PHIO fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.21, Equity is -1.31 and Total Capital is -1.62. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.9335 points at the first support level, and at 0.8469 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.0833, and for the 2nd resistance point, it is at 1.1465.
Phio Pharmaceuticals Corp [PHIO] reported earnings per share of -$1.14 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$1.43/share, meaning a difference of $0.29 and a surprise factor of 20.30%. By comparison, the stated earnings for the previous quarter ended on 12/30/2022 were -$2.4 per share as compared to estimates of -$3.24 per share, a difference of $0.84 representing a surprise of 25.90%.
Ratios To Look Out For
It is important to note that Phio Pharmaceuticals Corp [NASDAQ:PHIO] has a current ratio of 4.01. Also, the Quick Ratio is 4.01, while the Cash Ratio stands at 3.61.
Transactions by insiders
Recent insider trading involved Bitterman Robert J, President & CEO, that happened on Feb 26 ’24 when 2500.0 shares were purchased. President & CEO, Bitterman Robert J completed a deal on Jul 01 ’23 to buy 1000.0 shares. Meanwhile, President & CEO Bitterman Robert J bought 1000.0 shares on Jun 30 ’23.
